Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor
Ex vivo recovery and activation of dysfunctional, anergic, monocyte-derived dendritic cells from patients with operable breast cancer: critical role of IFN-alpha
The essential role of the in situ immune reaction in human colorectal cancer
Dendritic cell therapy in combination with interferon-alpha for the treatment of metastatic renal cell carcinoma
Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors
Recombinant Newcastle disease virus expressing human interleukin-2 serves as a potential candidate for tumor therapy
Detection and functional analysis of tumor infiltrating T-lymphocytes (TIL) in liver metastases from colorectal cancer
Antitumor effect of lung cancer vaccine with umbilical blood dendritic cells in reconstituted SCID mice
IFN-gamma down-regulates Hsp27 and enhances hyperthermia-induced tumor cell death in vitro and tumor suppression in vivo
[Immunotherapy for glioma]
Melanoma and lymphoma rejection associated with eosinophil infiltration upon intratumoral injection of dendritic and NK/LAK cells
Immunotherapy of pancreatic carcinoma
Radiotherapy with 8-MHz radiofrequency-capacitive regional hyperthermia for stage III non-small-cell lung cancer: the radiofrequency-output power correlates with the intraesophageal temperature and clinical outcomes
Functional T-cell responses generated by dendritic cells expressing the early HIV-1 proteins Tat, Rev and Nef
Efficiency of adjuvant active specific immunization with Newcastle disease virus modified tumor cells in colorectal cancer patients following resection of liver metastases: results of a prospective randomized trial
Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme
Engineering of highly immunogenic long-lived DC vaccines by antiapoptotic protein gene transfer to enhance cancer vaccine potency
Cancer immunotherapy using in vitro genetically modified targeted dendritic cells
Induction of HIV-specific T and B cell responses with a replicating and conditionally infectious lentiviral vaccine
Mechanisms involved in radiation enhancement of intratumoral dendritic cell therapy